Approach avoidance training for Obsessive-Compulsive Disorder

McLean Hospital, Belmont, MA
Targeting 2 different conditionsApproach avoidance training +3 moreN/ARecruitingResearch Sponsored by Mclean Hospital

Study Summary

This trial will examine if CBM-I or AAT is an effective addition to treatment as usual for OCD and related disorders.

Eligible Conditions
  • Obsessive-Compulsive Disorder

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You can use a computer for 20 minutes without any difficulty.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 0, 1, 2, 3, and 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 0, 1, 2, 3, and 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Average Score on Obsessive Beliefs Questionnaire
Secondary outcome measures
Change in Average Score on Behavioral Inhibition/Behavioral Activation Scales
Change in Average Score on Depressive Symptom Index Suicidality Subscale. There are 4 items scored from 0-3 with greater numbers indicating greater severity.
Change in Average Score on Yale-Brown Obsessive Compulsive Scale
+6 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognitive bias modification with treatment as usualExperimental Treatment1 Intervention
Participants in this group will receive usual treatment in the program and 8 sessions of a computerized cognitive training targeting interpretation bias
Group II: Approach avoidance training with treatment as usualExperimental Treatment1 Intervention
Participants in this group will receive usual treatment in the program and 8 sessions of a computerized cognitive training targeting automatic approach tendencies
Group III: Psychoeducation with treatment as usualPlacebo Group1 Intervention
Participants in this group will receive usual treatment in the program and 8 sessions of psychoeducation
Group IV: Inactive sham approach avoidance trainingPlacebo Group1 Intervention
Participants in this group will receive usual treatment in the program and 8 sessions of a sham approach avoidance training

Find a site

Who is running the clinical trial?

Mclean HospitalLead Sponsor
201 Previous Clinical Trials
16,695 Total Patients Enrolled
8 Trials studying Obsessive-Compulsive Disorder
243 Patients Enrolled for Obsessive-Compulsive Disorder

Media Library

Approach avoidance training Clinical Trial Eligibility Overview. Trial Name: NCT03799419 — N/A
Obsessive-Compulsive Disorder Research Study Groups: Psychoeducation with treatment as usual, Cognitive bias modification with treatment as usual, Inactive sham approach avoidance training, Approach avoidance training with treatment as usual
Obsessive-Compulsive Disorder Clinical Trial 2023: Approach avoidance training Highlights & Side Effects. Trial Name: NCT03799419 — N/A
Approach avoidance training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03799419 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Sep 2024